Compare AGNC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGNC | RVTY |
|---|---|---|
| Founded | 2008 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 11.8B |
| IPO Year | 2008 | N/A |
| Metric | AGNC | RVTY |
|---|---|---|
| Price | $11.41 | $95.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | $11.03 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 22.1M | 1.6M |
| Earning Date | 01-26-2026 | 02-02-2026 |
| Dividend Yield | ★ 12.68% | 0.29% |
| EPS Growth | ★ 58.06 | N/A |
| EPS | 1.47 | ★ 2.07 |
| Revenue | $1,797,000,000.00 | ★ $2,856,051,000.00 |
| Revenue This Year | N/A | $6.06 |
| Revenue Next Year | $1.88 | $5.15 |
| P/E Ratio | ★ $7.73 | $46.68 |
| Revenue Growth | ★ 84.69 | 3.67 |
| 52 Week Low | $7.85 | $81.36 |
| 52 Week High | $12.19 | $120.39 |
| Indicator | AGNC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 36.96 |
| Support Level | $11.15 | $93.70 |
| Resistance Level | $11.60 | $106.55 |
| Average True Range (ATR) | 0.26 | 4.40 |
| MACD | -0.07 | -1.69 |
| Stochastic Oscillator | 20.19 | 10.61 |
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.